Biomedical subjects
Publications and source records attributed to D Schanzlin.
The new eye shield described here incorporates the principles of a compound array that provides a significant improvement in vision (from hand movements to 20/100 or better) in a nonaccommodative eye, while retaining all other properties (protection, ventilation, reduction of glare) of eye shields used currently. It is recommended for routine use in patients after intraocular surgery and pupillary dilatation.
We measured circulating hemoglobin A1 (HbA1) and fasting plasma C-peptide concentrations in 100 diabetic patients. Pancreatic insulin reserve showed a negative correlation with HbA1 concentrations in nonobese, insulin-treated patients but not in obese patients, whether they were treated with insulin, oral agent, or diet alone. Patients with fasting C-peptide concentrations above 0.1 pmol/ml had significantly better metabolic control than did those with lower values. Anti-insulin antibodies were measured in 37 patients. There was no correlation between metabolic control and the affinity constants or binding capacities of these antibodies.